aXichem AB (FRA:A6X)

Market Cap	10.13M +56.6%
Revenue (ttm)	1.45M +114.6%
Net Income	-1.60M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.1255
Previous Close	0.1425
Day's Range	0.1255 - 0.1255
52-Week Range	0.0570 - 0.3230
Beta	n/a
RSI	42.95
Earnings Date	Feb 26, 2026

About aXichem AB

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Employees: 7
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A6X

Financial Performance

In 2024, aXichem AB's revenue was 8.57 million, an increase of 373.74% compared to the previous year's 1.81 million. Losses were -17.81 million, -14.41% less than in 2023.

Financial numbers in SEK